 |
PDBsum entry 5tob
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
5tob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Selectivity switch between fak and pyk2: macrocyclization of fak inhibitors improves pyk2 potency
|
|
Structure:
|
 |
Protein-tyrosine kinase 2-beta. Chain: a. Fragment: unp residues 414-692. Synonym: calcium-dependent tyrosine kinase,cadtk,calcium-regulated non-receptor proline-rich tyrosine kinase,cell adhesion kinase beta, cakb,focal adhesion kinase 2,fadk 2,proline-rich tyrosine kinase 2, related adhesion focal tyrosine kinase,raftk. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ptk2b, fak2, pyk2, raftk. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.12Å
|
R-factor:
|
0.212
|
R-free:
|
0.262
|
|
|
Authors:
|
 |
Z.E.Newby
|
|
Key ref:
|
 |
J.Farand
et al.
(2016).
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency.
Bioorg Med Chem Lett,
26,
5926-5930.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Oct-16
|
Release date:
|
29-Nov-17
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q14289
(FAK2_HUMAN) -
Protein-tyrosine kinase 2-beta from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1009 a.a.
245 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
26:5926-5930
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency.
|
|
J.Farand,
N.Mai,
J.Chandrasekhar,
Z.E.Newby,
J.Van Veldhuizen,
J.Loyer-Drew,
C.Venkataramani,
J.Guerrero,
A.Kwok,
N.Li,
Y.Zherebina,
S.Wilbert,
J.Zablocki,
G.Phillips,
W.J.Watkins,
R.Mourey,
G.T.Notte.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |